Magnetofection

Back

FluoMag Transfection Reagent

Fluorescent Magnetofection Reagents

Whatsapp

Overview

Overview

OZ Biosciences has created fluorescently-labeled magnetic nanoparticles for Magnetofection applications. FluoMag Transfection Reagents are as efficient as their non-labeled counterparts and allow you to visualize the nanoparticles in vitro during your experiments.
  • FluoMag-C corresponding to CombiMag (transfection reagent enhancer)
  • FluoMag-P corresponding to PolyMag (DNA transfection reagent)
  • FluoMag-S corresponding to SilenceMag (siRNA delivery)
  • FluoMag-V corresponding to ViroMag (viral transduction)
  • FluoMag-N corresponding to NeuroMag (neuron transfection)
Advantages of the Magnetofection technology
  • Easy cell labeling and tracking
  • Non toxic
  • Serum compatible
Sizes : 100 µL
Storage: +4°C and protect from the light
Shipping Conditions: Room temperature
  • This reagent needs to be used with a magnetic plate
CATALOG NUMBER UNIT SIZE
FN10100

FluoMag-N 100 µL

FC10100

FluoMag-C 100µL

FP10100

FluoMag-P 100µL

FS10100

FluoMag -S 100µL

FV10100

FluoMag-V 100µL

 

Applications

RECOMMENDED FOR:

  • Double labeling and co-localization studies using GFP or FITC labeled nucleic acids 
  • Transfection mechanisms follow (interaction with cells, intracellular pathway ...)
  • Fluorescent resonance energy transfer (FRET) assay
  • Analyze the association of vectors with the magnetic nanoparticles
 

Results

NIH-3T3 Transfection with FluoMag-P transfection reagent

Figure 1: NIH-3T3 transfection with FluoMag-P and pEGFP plasmid DNA. NIH-3T3 cells (5x104 cells/well), growing on coverslips, were transfected in 24-well plates with 1 µg of pEGFP plasmid and 1µL of  FluoMag-P per well as described in the Magnetofection instruction manual. At several times post-transfection, cells were fixed, stained with DAPI to detect nucleus (blue) and observed under a fluorescent microscope equipped with a CCD camera.

Transfection efficiency of FluoMagS transfection reagent

Figure 2: Transfection efficiency of FluoMag-S versus SilenceMag. GFP stably transfected MDCK and HeLa cells were plated the day before transfection in a 24-well plate. Cells were then treated with SilenceMag or FluoMag-S and siRNA (targeting GFP or targeting LacZ as control) as described in the SilenceMag instruction manual. Complexes were prepared with 1 μL of SilenceMag or FluoMag-S and 10nM (67.5ng) of siRNA. Cells were then transfected in 500 μL transfection volume. GFP expression level was monitored 72h post-transfection by detection of fluorescence intensity with a fluorometer.